549 related articles for article (PubMed ID: 38255314)
1. Targeting the Metabolic Paradigms in Cancer and Diabetes.
Bosso M; Haddad D; Al Madhoun A; Al-Mulla F
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255314
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium.
Mitaishvili E; Feinsod H; David Z; Shpigel J; Fernandez C; Sauane M; de la Parra C
Front Biosci (Landmark Ed); 2024 Mar; 29(3):99. PubMed ID: 38538285
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.
Jia D; Park JH; Jung KH; Levine H; Kaipparettu BA
Cells; 2018 Mar; 7(3):. PubMed ID: 29534029
[TBL] [Abstract][Full Text] [Related]
5. Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells.
Martinez-Outschoorn UE; Pestell RG; Howell A; Tykocinski ML; Nagajyothi F; Machado FS; Tanowitz HB; Sotgia F; Lisanti MP
Cell Cycle; 2011 Dec; 10(24):4208-16. PubMed ID: 22033146
[TBL] [Abstract][Full Text] [Related]
6. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Jia D; Lu M; Jung KH; Park JH; Yu L; Onuchic JN; Kaipparettu BA; Levine H
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3909-3918. PubMed ID: 30733294
[TBL] [Abstract][Full Text] [Related]
7. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection.
Qiu X; Li Y; Zhang Z
Cell Oncol (Dordr); 2023 Aug; 46(4):847-865. PubMed ID: 37040057
[TBL] [Abstract][Full Text] [Related]
9. Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype.
Ganapathy-Kanniappan S
Crit Rev Biochem Mol Biol; 2018 Dec; 53(6):667-682. PubMed ID: 30668176
[TBL] [Abstract][Full Text] [Related]
10. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
[TBL] [Abstract][Full Text] [Related]
11. Nonhormonal therapy for endometriosis based on energy metabolism regulation.
Kobayashi H; Shigetomi H; Imanaka S
Reprod Fertil; 2021 Dec; 2(4):C42-C57. PubMed ID: 35118411
[TBL] [Abstract][Full Text] [Related]
12. Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors.
Lee M; Hirpara JL; Eu JQ; Sethi G; Wang L; Goh BC; Wong AL
Redox Biol; 2019 Jul; 25():101073. PubMed ID: 30594485
[TBL] [Abstract][Full Text] [Related]
13. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.
Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Pavlides S; Tsirigos A; Ertel A; Pestell RG; Broda P; Minetti C; Lisanti MP; Sotgia F
Cell Cycle; 2011 Dec; 10(23):4047-64. PubMed ID: 22134189
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial and metabolic alterations in cancer cells.
Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V
Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093
[TBL] [Abstract][Full Text] [Related]
16. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
18. OXPHOS inhibitors, metabolism and targeted therapies in cancer.
Cadassou O; Jordheim LP
Biochem Pharmacol; 2023 May; 211():115531. PubMed ID: 37019188
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
Li N; Li H; Wang Y; Cao L; Zhan X
EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Oxidative Phosphorylation on Cancer Drug Resistance.
Zhao Z; Mei Y; Wang Z; He W
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]